Literature DB >> 20571607

Oxycodone combinations for pain relief.

R B Raffa1, J V Pergolizzi, D J Segarnick, R J Tallarida.   

Abstract

No single analgesic drug provides the perfect therapeutic/adverse effect profile for every pain condition. In addition to convenience and possibly improved compliance, a combination of analgesic drugs offers the potential, requiring verification, of providing greater pain relief and/or reduced adverse effects than the constituent drugs when used individually. We review here analgesic combinations containing oxycodone. We found surprisingly little preclinical information about the analgesic or adverse effect profiles of the combinations (with acetaminophen, paracetamol, nonsteroidal anti-inflammatory drugs, morphine, gabapentin or pregabalin). Clinical experience and studies suggest that the combinations are safe and effective and may offer certain advantages. As with all combinations, the profile of adverse effects must also be determined in order to provide the clinician with the overall benefit/risk assessment. Copyright 2010 Prous Science, S.A.U. or its licensors. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20571607      PMCID: PMC4046166          DOI: 10.1358/dot.2010.46.6.1470106

Source DB:  PubMed          Journal:  Drugs Today (Barc)        ISSN: 1699-3993            Impact factor:   2.245


  123 in total

Review 1.  What do we (not) know about how paracetamol (acetaminophen) works?

Authors:  K Toussaint; X C Yang; M A Zielinski; K L Reigle; S D Sacavage; S Nagar; R B Raffa
Journal:  J Clin Pharm Ther       Date:  2010-12       Impact factor: 2.512

2.  Substitution of gabapentin therapy with pregabalin therapy in neuropathic pain due to peripheral neuropathy.

Authors:  Cory Toth
Journal:  Pain Med       Date:  2010-01-22       Impact factor: 3.750

3.  Synergy between mu opioid ligands: evidence for functional interactions among mu opioid receptor subtypes.

Authors:  Elizabeth A Bolan; Ronald J Tallarida; Gavril W Pasternak
Journal:  J Pharmacol Exp Ther       Date:  2002-11       Impact factor: 4.030

4.  Trigeminal neuralgia treated with pregabalin in family medicine settings: its effect on pain alleviation and cost reduction.

Authors:  Concepción Pérez; María T Saldaña; Ana Navarro; Silvia Martínez; Javier Rejas
Journal:  J Clin Pharmacol       Date:  2009-03-19       Impact factor: 3.126

5.  Effects of single-dose gabapentin on postoperative pain and morphine consumption after cardiac surgery.

Authors:  Ferdi Menda; Ozge Köner; Murat Sayın; Mehmet Ergenoğlu; Süha Küçükaksu; Bora Aykaç
Journal:  J Cardiothorac Vasc Anesth       Date:  2010-01-06       Impact factor: 2.628

6.  Prescription and administration of opioids to hospital in-patients, and barriers to effective use.

Authors:  Bridin P Murnion; Danijela Gnjidic; Sarah N Hilmer
Journal:  Pain Med       Date:  2009-11-17       Impact factor: 3.750

7.  Characterisation of [3H]gabapentin binding to a novel site in rat brain: homogenate binding studies.

Authors:  N Suman-Chauhan; L Webdale; D R Hill; G N Woodruff
Journal:  Eur J Pharmacol       Date:  1993-02-15       Impact factor: 4.432

8.  Localization of [3H]gabapentin to a novel site in rat brain: autoradiographic studies.

Authors:  D R Hill; N Suman-Chauhan; G N Woodruff
Journal:  Eur J Pharmacol       Date:  1993-02-15       Impact factor: 4.432

9.  Effects of anticonvulsant drug gabapentin on the enzymes in metabolic pathways of glutamate and GABA.

Authors:  A Goldlust; T Z Su; D F Welty; C P Taylor; D L Oxender
Journal:  Epilepsy Res       Date:  1995-09       Impact factor: 3.045

10.  Gabapentin decreases morphine consumption and improves functional recovery following total knee arthroplasty.

Authors:  Hance Clarke; Sara Pereira; Deborah Kennedy; Ian Gilron; Joel Katz; Jeffrey Gollish; Joseph Kay
Journal:  Pain Res Manag       Date:  2009 May-Jun       Impact factor: 3.037

View more
  9 in total

1.  Cross-tolerance to cannabinoids in morphine-tolerant rhesus monkeys.

Authors:  L R Gerak; C Zanettini; W Koek; C P France
Journal:  Psychopharmacology (Berl)       Date:  2015-07-23       Impact factor: 4.530

2.  Interactions between cannabinoid receptor agonists and mu opioid receptor agonists in rhesus monkeys discriminating fentanyl.

Authors:  David R Maguire; Charles P France
Journal:  Eur J Pharmacol       Date:  2016-05-13       Impact factor: 4.432

3.  Combined Treatment with Morphine and Δ9-Tetrahydrocannabinol in Rhesus Monkeys: Antinociceptive Tolerance and Withdrawal.

Authors:  L R Gerak; C P France
Journal:  J Pharmacol Exp Ther       Date:  2016-03-02       Impact factor: 4.030

4.  Tramadol/paracetamol fixed-dose combination in the treatment of moderate to severe pain.

Authors:  Joseph V Pergolizzi; Mart van de Laar; Richard Langford; Hans-Ulrich Mellinghoff; Ignacio Morón Merchante; Srinivas Nalamachu; Joanne O'Brien; Serge Perrot; Robert B Raffa
Journal:  J Pain Res       Date:  2012-08-29       Impact factor: 3.133

5.  Combination Drug Therapy for Pain following Chronic Spinal Cord Injury.

Authors:  Aldric Hama; Jacqueline Sagen
Journal:  Pain Res Treat       Date:  2012-03-18

6.  A Quality Improvement Project to Reduce Combination Acetaminophen-opioid Prescriptions to Pediatric Orthopedic Patients.

Authors:  Thomas J Caruso; Sunny Trivedi; Whitney Chadwick; Shabnam Gaskari; Ellen Wang; Juan Marquez; Sara Lagasse; Madison Bailey; Kevin Shea
Journal:  Pediatr Qual Saf       Date:  2020-04-28

7.  Opioid-related overdose and chronic use following an initial prescription of hydrocodone versus oxycodone.

Authors:  Scott G Weiner; Michelle A Hendricks; Sanae El Ibrahimi; Grant A Ritter; Sara E Hallvik; Christi Hildebran; Roger D Weiss; Edward W Boyer; Diana P Flores; Lewis S Nelson; Peter W Kreiner; Michael A Fischer
Journal:  PLoS One       Date:  2022-04-05       Impact factor: 3.240

Review 8.  Pharmacogenomics of oxycodone: a narrative literature review.

Authors:  Nelly N Umukoro; Blessed W Aruldhas; Ryan Rossos; Dhanashri Pawale; Janelle S Renschler; Senthilkumar Sadhasivam
Journal:  Pharmacogenomics       Date:  2021-03-17       Impact factor: 2.533

9.  Different effects of oxycodone and remifentanil in patients undergoing ultrasound-guided percutaneous radiofrequency ablation of hepatic cancer: a randomized trial.

Authors:  Junbei Wu; Yunhong Lu; Xiaofei Cao
Journal:  Drug Des Devel Ther       Date:  2019-01-18       Impact factor: 4.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.